Rapid Micro Biosystems, Inc. Class A Common Stock earnings per share and revenue
On Nov 07, 2025, RPID reported earnings of -0.26 USD per share (EPS) for Q3 25, missing the estimate of -0.24 USD, resulting in a -4.04% surprise. Revenue reached 7.84 million, compared to an expected 7.91 million, with a -0.85% difference. The market reacted with a +12.73% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 11.58 million USD, implying an decrease of -15.38% EPS, and increase of 47.70% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.63%
FAQ
What were Rapid Micro Biosystems, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Rapid Micro Biosystems, Inc. Class A Common Stock reported EPS of -$0.26, missing estimates by -4.04%, and revenue of $7.84M, -0.85% below expectations.
How did the market react to Rapid Micro Biosystems, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved up 12.73%, changed from $2.75 before the earnings release to $3.10 the day after.
When is Rapid Micro Biosystems, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Feb 27, 2026.
What are the forecasts for Rapid Micro Biosystems, Inc. Class A Common Stock's next earnings report?
Based on 6
analysts, Rapid Micro Biosystems, Inc. Class A Common Stock is expected to report EPS of -$0.22 and revenue of $11.58M for Q4 2025.